share_log

康健國際醫療：截至2024年1月31日止之股份發行人的證券變動月報表

TOWN HEALTH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

香港交易所 ·  Feb 2 04:02
Summary by Moomoo AI
康健國際醫療於2024年2月2日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年1月31日的公司股本變動情況。報告顯示，公司普通股股份數目及法定/註冊股本在本月內無增減，結存維持在30,000,000,000股，每股面值0.01港元，總股本為300,000,000港元。優先股方面，同樣無變動，結存為375,000,000股，總股本為3,750,000港元。已發行普通股份亦無增減，本月底結存為6,773,522,452股。此外，公司於2022年8月26日發行的B批次及C批次可換股債券，到期日分別為2024年8月26日及2025年8月26日，轉換價為每股0.76港元，本月底已發行總額分別為120,000,000港元及116,000,000港元，並無本月內變動。公司秘書郭仲安確認，所有證券發行均已獲董事會授權批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
康健國際醫療於2024年2月2日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年1月31日的公司股本變動情況。報告顯示，公司普通股股份數目及法定/註冊股本在本月內無增減，結存維持在30,000,000,000股，每股面值0.01港元，總股本為300,000,000港元。優先股方面，同樣無變動，結存為375,000,000股，總股本為3,750,000港元。已發行普通股份亦無增減，本月底結存為6,773,522,452股。此外，公司於2022年8月26日發行的B批次及C批次可換股債券，到期日分別為2024年8月26日及2025年8月26日，轉換價為每股0.76港元，本月底已發行總額分別為120,000,000港元及116,000,000港元，並無本月內變動。公司秘書郭仲安確認，所有證券發行均已獲董事會授權批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
HealthCare International filed with Hong Kong Exchanges and Clearing Limited on February 2, 2024 its latest Securities Changes Monthly Report, reporting the changes in the company's share capital for the year ended January 31, 2024. The report shows that the number of ordinary shares and regulated/registered share capital of the company did not decrease during the month, with a cash reserve of 30,000,000,000 shares with a face value of HK$0.01 per share and a total share capital of HK$300,000,000. The preferred shares were unchanged, with 375,000,000 shares outstanding and a total share capital of HK$3,750,000. There was no increase in issued ordinary shares, with 6,773,522,452 shares outstanding at the end of the month. In addition, the Company's B Batch and C Batch Convertible Notes...Show More
HealthCare International filed with Hong Kong Exchanges and Clearing Limited on February 2, 2024 its latest Securities Changes Monthly Report, reporting the changes in the company's share capital for the year ended January 31, 2024. The report shows that the number of ordinary shares and regulated/registered share capital of the company did not decrease during the month, with a cash reserve of 30,000,000,000 shares with a face value of HK$0.01 per share and a total share capital of HK$300,000,000. The preferred shares were unchanged, with 375,000,000 shares outstanding and a total share capital of HK$3,750,000. There was no increase in issued ordinary shares, with 6,773,522,452 shares outstanding at the end of the month. In addition, the Company's B Batch and C Batch Convertible Notes issued on August 26, 2022, with maturity dates of August 26, 2024 and August 26, 2025, at a conversion price of HK$0.76 per share. The total amounts issued at the end of the month were HK$120,000,000 and HK$116,000,000, respectively, unchanged during the month. Company Secretary Kwok Chung-An confirmed that all securities issues have been authorised by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more